OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Correction: Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
Henry T. Peng, Shawn G. Rhind, Andrew Beckett
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 6, pp. e31554-e31554
Open Access | Times Cited: 17
Henry T. Peng, Shawn G. Rhind, Andrew Beckett
JMIR Public Health and Surveillance (2021) Vol. 7, Iss. 6, pp. e31554-e31554
Open Access | Times Cited: 17
Showing 17 citing articles:
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Frederick K. Korley, Valerie Durkalski‐Mauldin, Sharon D. Yeatts, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 21, pp. 1951-1960
Open Access | Times Cited: 140
Frederick K. Korley, Valerie Durkalski‐Mauldin, Sharon D. Yeatts, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 21, pp. 1951-1960
Open Access | Times Cited: 140
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics
Lennox Chitsike, Penelope J. Duerksen-Hughes
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 42
Lennox Chitsike, Penelope J. Duerksen-Hughes
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 42
Immersive Realities: A Comprehensive Guide from Virtual Reality to Metaverse
Preet Kawal Singh Dhillon, Hasan Tınmaz
Journal for the Education of Gifted Young Scientists (2024)
Open Access | Times Cited: 8
Preet Kawal Singh Dhillon, Hasan Tınmaz
Journal for the Education of Gifted Young Scientists (2024)
Open Access | Times Cited: 8
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-Derived Immunoglobulin
Andreas Volk, Caroline Covini-Souris, Denis Kuehnel, et al.
BioDrugs (2021) Vol. 36, Iss. 1, pp. 41-53
Open Access | Times Cited: 33
Andreas Volk, Caroline Covini-Souris, Denis Kuehnel, et al.
BioDrugs (2021) Vol. 36, Iss. 1, pp. 41-53
Open Access | Times Cited: 33
Longitudinal analysis of antibody decay in convalescent COVID-19 patients
Weiming Xia, Mingfei Li, Ying Wang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Weiming Xia, Mingfei Li, Ying Wang, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Convalescent serum-derived exosomes: Attractive niche as COVID-19 diagnostic tool and vehicle for mRNA delivery
Krishnan Anand, Prakash Gangadaran, Vivek P. Chavda, et al.
Experimental Biology and Medicine (2022) Vol. 247, Iss. 14, pp. 1244-1252
Open Access | Times Cited: 18
Krishnan Anand, Prakash Gangadaran, Vivek P. Chavda, et al.
Experimental Biology and Medicine (2022) Vol. 247, Iss. 14, pp. 1244-1252
Open Access | Times Cited: 18
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)
Ai Phuong Tran, Daniel Tassone, Nik S. Ding, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002871-e002871
Open Access | Times Cited: 6
Ai Phuong Tran, Daniel Tassone, Nik S. Ding, et al.
RMD Open (2023) Vol. 9, Iss. 1, pp. e002871-e002871
Open Access | Times Cited: 6
COVID-Bot, an Intelligent System for COVID-19 Vaccination Screening: Design and Development
Chinedu Wilfred Okonkwo, Lateef Babatunde Amusa, Hossana Twinomurinzi
JMIR Formative Research (2022) Vol. 6, Iss. 10, pp. e39157-e39157
Open Access | Times Cited: 6
Chinedu Wilfred Okonkwo, Lateef Babatunde Amusa, Hossana Twinomurinzi
JMIR Formative Research (2022) Vol. 6, Iss. 10, pp. e39157-e39157
Open Access | Times Cited: 6
Combining Machine Learning, Patient-Reported Outcomes, and Value-Based Health Care: Protocol for Scoping Reviews
Tyler Raclin, Amy Price, Christopher D Stave, et al.
JMIR Research Protocols (2022) Vol. 11, Iss. 7, pp. e36395-e36395
Open Access | Times Cited: 6
Tyler Raclin, Amy Price, Christopher D Stave, et al.
JMIR Research Protocols (2022) Vol. 11, Iss. 7, pp. e36395-e36395
Open Access | Times Cited: 6
Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID
Junzheng Wu, Huichuan Yang, Ding Yu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 3
Junzheng Wu, Huichuan Yang, Ding Yu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 3
Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
Mariana Ulinici, Alen Suljič, Monica Poggianella, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 637-637
Open Access | Times Cited: 2
Mariana Ulinici, Alen Suljič, Monica Poggianella, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 637-637
Open Access | Times Cited: 2
Association between ABO blood groups and the risk of infection with SARS-CoV-2 in Iraq
Abdulhakeem D. Hussein, Ekhlas Aziz Bakr, Mohammed Hadi Ali Al‐Jumaili
Journal of International Medical Research (2022) Vol. 50, Iss. 11, pp. 030006052211331-030006052211331
Open Access | Times Cited: 3
Abdulhakeem D. Hussein, Ekhlas Aziz Bakr, Mohammed Hadi Ali Al‐Jumaili
Journal of International Medical Research (2022) Vol. 50, Iss. 11, pp. 030006052211331-030006052211331
Open Access | Times Cited: 3
Persistent Vascular Complications in Long COVID: The Role of ACE2 Deactivation, Microclots, and Uniform Fibrosis
Christina-Michailia Sideratou, Christos Papaneophytou
Infectious Disease Reports (2024) Vol. 16, Iss. 4, pp. 561-571
Open Access
Christina-Michailia Sideratou, Christos Papaneophytou
Infectious Disease Reports (2024) Vol. 16, Iss. 4, pp. 561-571
Open Access
Convalescent plasma treatment for patients of 80 years and older with COVID-19 pneumonia
Íñigo Romón, Juan José Domínguez-García, J.L. Arroyo, et al.
BMC Geriatrics (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Íñigo Romón, Juan José Domínguez-García, J.L. Arroyo, et al.
BMC Geriatrics (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS‐CoV ‐2 in a US ‐like population
Natalya Kostandova, Emmanuel F. Drabo, Karine Yenokyan, et al.
Transfusion (2022) Vol. 63, Iss. 1, pp. 92-103
Open Access | Times Cited: 2
Natalya Kostandova, Emmanuel F. Drabo, Karine Yenokyan, et al.
Transfusion (2022) Vol. 63, Iss. 1, pp. 92-103
Open Access | Times Cited: 2
SARS-CoV-2 Neutralization in Convalescent Plasma and Commercial Lots of Plasma-derived Immunoglobulin
Andreas Volk, Caroline Covini-Souris, Denis Kuehnel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Andreas Volk, Caroline Covini-Souris, Denis Kuehnel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
